HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors

► Antibodies to HIV Tat protein attenuate Tat-mediated neurotoxicity. ► Tat immune complexes also block neurotoxicity caused by NMDA receptor agonists. ► Vaccine therapies targeting Tat may prevent HIV-associated cognitive impairment.